Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

U.S. House Votes to Repeal Obamacare’s Independent Payment Advisory Board

Washington, DC, November 6, 2017 — Nathaniel Weixel reports in The Hill that the U.S. House of Representatives on Thursday, November 2 voted to repeal a controversial Medicare cost-cutting board that has drawn the ire of both parties.

Lawmakers voted 307-111 to abolish what is known as the Independent Payment Advisory Board (IPAB).  The board is tasked with coming up with Medicare cuts if spending rises above a certain threshold but has been criticized as outsourcing the work of Congress.

Ten of New Jersey’s 12 members of the House voted in favor of H.R. 849, the “Protecting Seniors Access to Medicare Act.”

Reps. Donald Norcross (D-1), Frank LoBiondo (R-2), Tom MacArthur (R-3), Chris Smith (R-4), Josh Gottheimer (D-5), Leonard Lance (R-7), Albio Sires (D-8), Bill Pascrell (D-9), Rodney Frelinghuysen (R-11), and Bonnie Watson Coleman (D-12) all voted in favor of repeal.

In addition, Rep. Bill Pascrell, Jr. (D-9) a member of the House Ways and Means Committee, was one of only two Democrats to vote in favor of repeal when the Committee considered the bill.

IPAB has also been the target of the false attacks from Obamacare opponents that the board enables unelected bureaucrats to helm “death panels.”

Weixel reports that the bill now moves to the Senate, but it’s not likely the upper chamber will act before the end of the year.  Even then, Republicans may not get the 60 votes needed to pass it as a stand-alone bill.

Nobody has been appointed to the panel and budget experts have estimated they don’t expect IPAB to be triggered until 2021 or 2022.  Democrats say Congress has the authority to overrule any recommendations the panel could make.

The White House on November 1 signaled support for the bill, noting in a statement that IPAB repeal was part of President Trump’s budget request.

For Weixel’s full story, click here.